Literatur
Uppara, M.; Adaba, F.; Askari, A.; Clark, S.; Hanna, G; Athanasiou, T.; Faiz, O.; 2015
A systematic review and meta-analysis of the diagnostic accuracy of pyruvate kinase M2 isoenzymatic assay in diagnosing colorectal cancer. World Journal of Surgical Oncology 2015 Feb 13; doi: 10.1186/s12957-015-0446-4. PMID: 25888768
Kim, Y.C.; Kim, J.H.; Cheung, D.Y.; Kim, T.H.; Jun, E.J.; Oh, J.W.; Kim, C.W.; Chung, W.C.; Kim, B.W.; Kim, S.S.; Kim, J.I.; Park, S.H.; Kim JK.; 2014
The Usefulness of a Novel Screening Kit for Colorectal Cancer Using the Immunochromatographic Fecal Tumor M2 Pyruvate Kinase Test. Gut and Liver 2014 Dec 5. doi: 10.5009/gnl13457. [Epub ahead of print]
Leen, R.; Seng-Lee, C.; Holleran, G.; O’Morain, C.; McNamara, D.; 2014
Comparison of faecal M2-PK and FIT in a population-based bowel cancer screening cohort. European Journal of Gastroenterology & Hepatology 2014, 26 (5): 514-518.
Tonus, C.; Sellinger, M.; Koss, K.; Neupert, G.; 2012
Faecal pyruvate kinase isoenzyme type M2 for colorectal cancer screening: A meta-analysis. World Journal of Gastroenterology 2012, 18(30): 4004-4011
Parente, F.; Marino, B.; Ilardo, A.; Fracasso, P.; Zullo, A.; Hassan, C.;, Moretti, R.; Cremaschini, M.; Ardizzoia, A.; Saracino, I. ; Perna, F. ; Vaira, D. ; 2012
A combination of faecal tests for the detection of colon cancer: a new strategy for an appropriate selection of referrals to colonoscopy? A prospective multicentre Italian study. European Journal of Gastroenterology & Hepatology 2012, 24 (10): 1145-1152.
Mazurek, S.; 2010
M2-PK-Test zur Früherkennung von kolorektalen Karzinomen. EHK 2010, 59: 200-205
Koss, K.; Maxton, D.; Jankowski, J.A.Z.; 2008
Faecal dimeric M2 pyruvate kinase in colorectal cancer and polyps correlates with tumour staging and surgical intervention. Colorectal Disease, 2008, 10(3): 244-248
Ewald, N.; Schaller, M.; Bayer, M.; Akinci, A.; Bretzel, R.G.; Klör, H.U.; Hardt, P.D.; 2007
Fecal Pyruvate Kinase-M2 (Tumor M2-PK) Measurement: A New Screening Concept for Colorectal Cancer. Anticancer Research 2007, 27(4A): 1949-1952
Kumar, Y.; Tapuria, N.; Kirmani, N.; Davidson, B.R.; 2007
Tumour M2-pyruvate kinase: a gastrointestinal cancer marker. European Journal of Gastroenterology & Hepatology 2007, 19(3): 265-276
Tonus, C.; Neupert, G.; Sellinger, M.; 2006
Colorectal cancer screening by non-invasive metabolic biomarker fecal tumor M2-PK, World Journal of Gastroenterology 2006, 12(43): 7007-7011
Ewald, N.; Toepler, M.; Akinci, A.; Klör, H.U.; Bretzel, R.G.; Hardt, P.D.; 2005
Pyruvatkinase M2 (Tumor M2-PK) im Stuhl als Screeningparameter für kolorektale Neoplasien. Eine Übersicht über bisher publizierte Daten, Zeitschrift für Gastroenterologie 2005, 43: 1313-1317
Hardt, P.D.; Mazurek, S.: Toepler, M.; Schlierbach, P.; Bretzel, R.G.; Eigenbrodt, E.; Kloer, H.U.; 2004
Faecal tumor M2 pyruvate kinase: a new, sensitve screening tool for colorectal cancer, British Journal of Cancer 2004, 91: 980-984
Hardt, P.D.; Toepler, M.; Schlierbach, P.; Ngoumou, B.; Rupp, J.; Nalop, J.; Klör, H.U.; 2003
Messung der Tumor M2-Pyruvatkinase im Stuhl als Screening-Marker für kolorektale Karzinome, MedReview 5/2003, S. 14-16
Hardt, P.D.; Ngoumou, B.; Rupp, J.; Kloer, H.U.; 2003
Measurement of fecal Pyruvate Kinase Type M2 (Tumor M2-PK) Concentrations in Patients with Gastric Cancer, colorectal Cancer Colorectal Adenomas and Controls; Anticancer Research 2003, 23(2A): 851-854
Hardt, P.D., Toepler, M., Ngoumou, B., Rupp, J., Kloer, H.U.; 2003
Fecal Pyruvate Kinase Concentrations (ELISA based on a Combination Of Clone 1 and Clone 3 Antibodies) for Gastric Cancer Screening, Anticancer Research 2003, 23(2A): 855-858